将重病照护计划适配为通过远程医疗向老年血液系统恶性肿瘤患者提供
本研究将重病照护计划(SICP)适配为远程医疗形式,用于老年急性髓系白血病(AML)或骨髓增生异常综合征(MDS)患者,并开展单中心定性研究,共45名参与者(25名临床医生、15名老年患者、5名照护者)。参与者一致认为SICP有助于患者与医疗团队分享个人价值观,并归纳出四个定性主题。适配后的SICP可能为患者提供分享重要事项的机会,并可能帮助肿瘤医生使诊疗与患者价值观一致。
要点
- 临床医生、患者和照护者均认为SICP有助于老年AML或MDS患者与医疗团队分享个人价值观。
- 定性分析归纳出四个主题:远程医疗可行、老年患者技术经验有限但愿意学习、对话有助于理解诊断与预后、对话应常规化。
- 适配后的SICP正在进行单臂先导研究(Wilmot Cancer Institute,NCT04745676)。
核心结论
- 适配后的SICP可能为老年AML或MDS患者提供与医疗团队分享最重要事项的机会,并可能帮助肿瘤医生使患者诊疗与患者价值观一致。
研究设计与样本
- 单中心定性研究,共45名参与者(25名临床医生、15名老年AML或MDS患者、5名照护者)。
主要发现
- 参与者(临床医生、患者或照护者)均同意SICP有助于老年AML或MDS患者与医疗团队分享个人价值观。
- 归纳出四个定性主题:重病对话可通过远程医疗进行;老年患者使用技术经验有限但愿意且能够学习;患者认为重病对话有助于更好理解AML或MDS诊断与预后;重病对话应常规化而非特殊化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) experience intense inpatient health care at the end-of-life stage. Early advance care planning may improve care at the end of life for patients with AML or MDS. The Serious Illness Care Program (SICP) is a multicomponent, communication intervention developed to improve conversations about values for patients with serious illnesses. The SICP has been shown to improve the quality and frequency of advance care planning discussions. We adapted the SICP for delivery via telehealth to older patients with AML or MDS. We conducted a single-center qualitative study of 45 participants (25 clinicians, 15 older patients with AML or MDS, and 5 caregivers). Participants, whether clinicians, patients, or caregivers, agreed that the SICP would help older patients with AML or MDS to share their personal values with their care team. Four qualitative themes emerged from our data: (1) serious illness conversations can be conducted via telehealth, (2) older patients have limited experience using technology but are willing and able to learn, (3) patients feel that serious illness conversations will help them understand their AML or MDS diagnosis and prognosis better, and (4) serious illness conversations should be common and routine, not extraordinary. The adapted SICP may provide older patients with AML or MDS an opportunity to share what matters most to them with their care team and may assist oncologists in aligning patient care with patient values. The adapted SICP is the subject of an ongoing single-arm pilot study at the Wilmot Cancer Institute (clinicaltrials.gov identifier: NCT04745676).
引用
- LoCastro M, Sanapala C, Mendler JH, et al. Adaptation of Serious Illness Care Program to be delivered via telehealth for older patients with hematologic malignancy. Blood Adv. 2023. PMID: 36521100. doi:10.1182/bloodadvances.2022008996
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。